News
Quotient Sciences Invests in Drug Substance Manufacturing Facility
Quotient Sciences, a drug development and manufacturing company, is investing £6.3 million pounds ($8.6mn) in its recently acquired manufacturing facility in Alnwick, UK. The...
Drug Research
Innovent Biologics, Bolt Biotherapeutics Enter Immuno oncology Alliance
Innovent Biologics, Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines for cancer, metabolic, autoimmune and other diseases, and Bolt Biotherapeutics, Inc., a...
News
SK bioscience & GSK initiate phase 3 trial of adjuvanted Covid-19 vaccine candidate
SK bioscience (SK) and GlaxoSmithKline (GSK) announced the initiation of a phase 3 clinical study of SK’s Covid-19 vaccine candidate, GBP510, in combination with...
News
Abbott introduces single-dose formulation of carbetocin for prevention of postpartum haemorrhage in India
Abbott, the global healthcare company has announced the introduction of a room-temperature-stable, single-dose formulation of carbetocin in India, which is available in convenient vials,...
News
Drug Substance Freezing and Why It Doesn’t Have To Be a Bottleneck
Drug substance freezing has moved on.
Traditionally it was inefficient in a multitude of ways. Issues such as product loss, reduction of product potency, or...
News
Rapid Development and Industrialization of a COVID-19 Viral Vector Vaccine Manufacturing Process
The year 2020 will go down in history books as a year that changed the world and helped drug manufacturing to evolve. When the...
News
Agilex Biolabs Partners with Endpoints News for the First Webinar on Rapid Vaccine Development in Australia
Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on "Non-clinical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read